| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate |
2001-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0a1ae168912527bad4afa1ca866375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56533a14eaac0dfbae6c9b7de8eaac14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4150120860790addc6b4bc6dbec36fc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a48e1b2c7be495d57d8a37e932e2552 |
| publicationDate |
2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-100571772-C |
| titleOfInvention |
The antagonist of integrin receptors alpha v β 3 and/or α v β 5 is used for the treatment of purposes in the medicine of ophthalmic in preparation |
| abstract |
The invention provides the employing integrin receptors alphan v βn 3 And/or αn v βn 5 Antagonist be used for preventing and/or treating a purposes that generates the medicine of the patient's ophthalmic that causes owing to the eye medium vessels in preparation. |
| priorityDate |
2000-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |